| Nectar Lifescience Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.65 | 0.75 | 0.82 | 0.77 | 0.75 |
| Long Term Debt-Equity Ratio | 0.17 | 0.24 | 0.20 | 0.11 | 0.13 |
| Current Ratio | 1.32 | 1.33 | 1.17 | 1.12 | 1.18 |
| Fixed Assets | 1.22 | 1.12 | 1.23 | 1.15 | 1.76 |
| Inventory | 2.79 | 2.62 | 3.09 | 2.26 | 2.79 |
| Debtors | 5.85 | 4.81 | 4.69 | 4.57 | 5.51 |
| Interest Cover Ratio | 1.21 | -0.02 | 1.32 | 0.47 | 1.28 |
| PBIDTM (%) | 8.63 | 3.29 | 8.35 | 6.41 | 8.42 |
| PBITM (%) | 5.47 | -0.10 | 5.39 | 3.00 | 6.12 |
| PBDTM (%) | 4.10 | -1.26 | 4.26 | 0.06 | 3.66 |
| CPM (%) | 3.41 | -0.22 | 3.79 | 0.71 | 3.44 |
| APATM (%) | 0.26 | -3.61 | 0.83 | -2.71 | 1.14 |
| ROCE (%) | 5.96 | -0.09 | 5.28 | 2.71 | 8.17 |
| RONW (%) | 0.47 | -5.85 | 1.48 | -4.35 | 2.68 |